Pathology of Acute and Chronic Hepatitis D

  • Michael A. Gerber


Since the discovery of the delta antigen by Rizzetto et al.1 10 years ago, the pathology of delta hepatitis has been described in detail. In recent years, several studies recorded significant differences in the clinical course and pathologic findings of hepatitis delta virus (HDV) infection in South America as opposed to those in North America and Europe. This chapter summarizes these interesting observations.


Chronic Hepatitis Hepatitis Delta Virus HBsAg Carrier Microvesicular Steatosis Reye Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rizzetto M, Canese MG, Arico S, et al: Immunofluorescence detection of new antigen-antibody system (δ/anti-δ) associated to hepatitis S virus in liver and in serum of HBsAg carriers. Gut 18:997–1003, 1977.PubMedCrossRefGoogle Scholar
  2. 2.
    Hadler SC, Demonzon M, Ponzetto A, et al: Delta virus infection and severe hepatitis. An epidemic in the Yupca Indians of Venezuela. Ann Intern Med. 100:339–344, 1984.PubMedGoogle Scholar
  3. 3.
    Ljunggren KE, Patarroyo ME, Engle R, et al: Viral hepatitis in Colombia: A study of the “Hepatitis of the Sierra Nevada de Santa Marta.” Hepatology 5:299–304, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Buitrago B, Hadler SC, Popper H, et al: Epidemiologie aspects of Santa Marta hepatitis over a 40-year period. Hepatology 6:1292–1296, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Popper H, Thung SN, Gerber MA, et al: Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology 3:906–912, 1983.PubMedCrossRefGoogle Scholar
  6. 6.
    Buitrago B, Popper H, Hadler SC, et al: Specific histologie features of Santa Marta hepatitis: A severe form of hepatitis δ-virus infection in Northern South America. Hepatology 6:1285–1291, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Smedile A, Verme G, Cargnel A, et al: Influence of delta infection on severity of hepatitis B. Lancet 2:945–947, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Govindarajan S, Chin KP, Redeker AG, et al: Fulminant S viral hepatitis: Role of delta agent. Gastroenterology 86:1417–1420, 1984.PubMedGoogle Scholar
  9. 9.
    Govindarajan S, De Cock KM, Peters RL: Morphologic and immunohistochemical features of fulminant delta hepatitis. Hum Pathol 16:262–267, 1985.PubMedCrossRefGoogle Scholar
  10. 10.
    De Cock KM, Govindarajan S, Chin KP, et al: Delta hepatitis in the Los Angeles area: A report of 126 cases. Ann Intern Med 105:108–114, 1986.PubMedGoogle Scholar
  11. 11.
    Verme G, Amoroso P, Lettieri G, et al: A histological study of hepatitis delta virus liver disease. Hepatology 6:1303–1307, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Govindarajan S, De Cock KM, Redeker AG: Natural Course of delta superinfection in chronic hepatitis S virus-infected patients: Histopathologic study with multiple liver biopsies. Hepatology 6:640–644, 1986.PubMedCrossRefGoogle Scholar
  13. 13.
    Kanel GC, Govindarajan S, Peters RL: Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med. 101:51–54, 1984.PubMedGoogle Scholar
  14. 14.
    Chu C-M, Farci P, Liaw Y-F, et al: The role of delta superinfection in acute exacerbations of chronic type S hepatitis. Liver 6:26–29, 1986.PubMedGoogle Scholar
  15. 15.
    Colombo M, Cambieri R, Rumi MG, et al: Long-term delta superinfection in hepatitis S surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 85:235–239, 1983.PubMedGoogle Scholar
  16. 16.
    Maggiore G, Hadchouel M, Sessa F, et al: A retrospective study of the role of delta agent infection in children with HBsAg-positive chronic hepatitis. Hepatology 5:7–9, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Chen DS, Lai MY, Sung JL: δ Agent infection in patients with chronic liver diseases and hepatocellular carcinoma—An infrequent finding in Taiwan. Hepatology 4:502–503, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    Rizzetto M, Verme G, Recchia S, et al: Chronic hepatitis in carriers of hepatitis S surface antigen, with intrahepatic expression of the delta antigen. Ann Intern Med 98:437–441, 1983.PubMedGoogle Scholar
  19. 19.
    Govindarajan S, Kanel G, Peters RL: Prevalence of delta-antibody among chronic hepatitis S virus infected patients in the Los Angeles area: Its correlation with liver biopsy diagnosis. Gastroenterology 85:160–162, 1983.PubMedGoogle Scholar
  20. 20.
    Shiels MT, Czaja AJ, Taswell HF, et al: Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience. Gastroenterology 89:1230–1234, 1985.PubMedGoogle Scholar
  21. 21.
    Stocklin E, Gudat F, Krey G, et al: δ Antigen in hepatitis B: Immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology 1:238–242, 1981.PubMedCrossRefGoogle Scholar
  22. 22.
    Rizzetto M, Canese MG, Gerin JL, et al: Transmission of the hepatitis S virus-associated delta antigen to chimpanzees. J Infect Dis 141:590–602, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Hadziyannis SJ, Sherman M, Lieberman HM, et al: Liver disease activity and hepatitis S virus replication in chronic delta antigen-positive hepatitis S virus carriers. Hepatology 5:544–547, 1986.CrossRefGoogle Scholar
  24. 24.
    Thung SN, Gerber MA: Immunohistochemical study of delta antigen in an American Metropolitan population. Liver 3:392–397, 1983.PubMedGoogle Scholar
  25. 25.
    Smedile A, Rizzetto M, Denniston K, et al: Type D hepatitis: The clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology 6:1297–1302, 1986.PubMedCrossRefGoogle Scholar
  26. 26.
    Govindarajan S, Valinluck B: Serum hepatitis S virus-DNA in chronic hepatitis S and delta infection. Arch Pathol Lab Med 109:398–399, 1985.PubMedGoogle Scholar
  27. 27.
    Krogsgaard K, Kryger P, Aldershvile J, et al: Delta infection and suppression of hepatitis S virus replication in chronic HBsAg carriers. Hepatology 7:42–45, 1987.PubMedCrossRefGoogle Scholar
  28. 28.
    Rizzetto M, Verme G, Gerin JL, et al: Hepatitis delta virus disease, in Popper H, Schaffner F (eds): Progress in Liver Diseases, Vol. 8. Grune & Stratton, Orlando, Florida, 1986, pp. 132–146.Google Scholar
  29. 29.
    Canese MG, Rizzetto M, Arico S, et al: An ultrastructural and immunohistochemical study on the δ antigen associated with the hepatitis S virus. J Pathol 128:169–175, 1979.PubMedCrossRefGoogle Scholar
  30. 30.
    Canese MG, Rizzetto M, Novara R, et al: Experimental infection of chimpanzees with the HBsAg-associated delta (δ) agent: An ultrastructural study. J Med Virol 13:63–72, 1984.PubMedCrossRefGoogle Scholar
  31. 31.
    Kojima T, Calles F, Desmyter J, et al: Immune electron microscopy of hepatitis δ-antigen in hepatocytes. Lab Invest 55:217–225, 1986.PubMedGoogle Scholar
  32. 32.
    Kamimura T, Ponzetto A, Bonino F, et al: Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis. Hepatology 3:631–637, 1983.PubMedCrossRefGoogle Scholar
  33. 33.
    Shimizu YK, Purcell RH, Gerin JL, et al: Further studies by immunofluorescence of the monoclonal antibodies associated with experimental Non-A, Non-B hepatitis in chimpanzees and their relation to D hepatitis. Hepatology 6:1329–1333, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Popper H, Buitrago B, Hadler SC, et al: Pathology of hepatitis delta infection in Amazon basin, in Rizzetto M, Gerin JL, Purcell RH (eds): The Hepatitis Delta Virus and Its Infection. Alan R. Liss, New York, 1987, pp. 121–128.Google Scholar
  35. 35.
    Gerber MA, Thung SN: The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in liver. Hum Pathol 18:771–774, 1987.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Michael A. Gerber
    • 1
  1. 1.Department of PathologyTulane University School of MedicineNew OrleansUSA

Personalised recommendations